FDA warns against Impax Hayward manufacturing facility
The FDA has warned the company for not adhering current good manufacturing practice (cGMP) for finished pharmaceuticals. The FDA has found deviations related to sampling and testing of
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
A research conducted by LifeCycle Pharma demonstrated that certain types of intravenous chemotherapy can be modified, utilizing LifeCycle Pharma technologies, to pill-based therapy. Herlev Hospital Oncology Department chief
Semuloparin is an investigational selectively engineered Ultra-LMWH (low molecular weight heparin) with enriched anti-thrombin binding sites. Semuloparin reduced the risk of this type of blood clots without increasing